Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease - Join Clinical Trial NCTNCT06462469
How to Join This Clinical Trial - NCTNCT06462469
Learn how to participate in this PHASE4 trial studying an investigational therapy for Steroid-refractory Acute Graft Versus Host Disease. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Steroid-refractory Acute Graft Versus Host Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Steroid-refractory Acute Graft Versus Host Disease
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE4 - Research study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06462469 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 15 locations. Find a study site near you:
Clinical Research Site
Guangzhou, Guangdong 510000 - China
Status: RECRUITING
Clinical Research Site
Guangzhou, Guangdong 510515 - China
Status: RECRUITING
Clinical Research Site
Zhengzhou, Henan 450052 - China
Status: RECRUITING
Clinical Research Site
Wuhan, Hubei 430030 - China
Status: RECRUITING
Clinical Research Site
Chang Chun, Jilin 130021 - China
Status: RECRUITING
Clinical Research Site
Xian, Shanxi 710061 - China
Status: RECRUITING
Clinical Research Site
Chengdu, Sichuan 610072 - China
Status: RECRUITING
Clinical Research Site
Hangzhou, Zhejiang 310003 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100028 - China
Status: RECRUITING
Clinical Research Site
Beijing, 100034 - China
Status: RECRUITING
And 5 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE4 clinical trial for Steroid-refractory Acute Graft Versus Host Disease:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships